Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 1;9(3):a031799.
doi: 10.1101/cshperspect.a031799.

Stem Cell-Derived Culture Models of Hepatitis E Virus Infection

Viet Loan Dao Thi  1 , Xianfang Wu  1 , Charles M Rice  1
Affiliations
Review

Stem Cell-Derived Culture Models of Hepatitis E Virus Infection

Viet Loan Dao Thi et al. Cold Spring Harb Perspect Med. .

Abstract

Similar to other hepatotropic viruses, hepatitis E virus (HEV) has been notoriously difficult to propagate in cell culture, limiting studies to unravel its biology. Recently, major advances have been made by passaging primary HEV isolates and selecting variants that replicate efficiently in carcinoma cells. These adaptations, however, can alter HEV biology. We have explored human embryonic or induced pluripotent stem cell (hESC/iPSC)-derived hepatocyte-like cells (HLCs) as an alternative to conventional hepatoma and hepatocyte cell culture systems for HEV studies. HLCs are permissive for nonadapted HEV isolate genotypes (gt)1-4 replication and can be readily genetically manipulated. HLCs, therefore, enable studies of pan-genotype HEV biology and will serve as a platform for testing anti-HEV treatments. Finally, we discuss how hepatocyte polarity is likely an important factor in the maturation and spread of infectious HEV particles.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Stem cell culture models of hepatitis E virus (HEV) infection. Cells collected from identified HEV-positive individuals can be reprogrammed to generate induced pluripotent stem cells (iPSCs). Relevant single nucleotide polymorphisms (SNPs) can be repaired or introduced into established human embryonic or induced pluripotent stem cell (hESC)/iPSC lines using CRISPR-Cas9, followed by differentiation to the cell type of interest. Differentiated cells can be directly infected with HEV isolates from patients or animals for modeling virus–host interactions in a dish.
Figure 2.
Figure 2.
Hepatocyte polarity and hepatitis E virus (HEV) secretion. HEV particle release from hepatocytes with (A) hepatic, (B) columnar, or (C) no polarity. Blue boxes in A and B are tight junctions separating apical and basal membranes.
See this image and copyright information in PMC

References

    1. Agrawal S, Gupta D, Panda SK. 2001. The 3′ end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp). Virology 282: 87–101. - PubMed
    1. Allweiss L, Gass S, Giersch K, Groth A, Kah J, Volz T, Rapp G, Schobel A, Lohse AW, Polywka S, et al. 2016. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation. J Hepatol 64: 1033–1040. - PubMed
    1. Ansari IH, Nanda SK, Durgapal H, Agarawal S, Mohanty SK, Gupta D, Jameel S, Panda SK. 2000. Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1). J Med Virol 60: 275–283. - PubMed
    1. Belouzard S, Danneels A, Feneant L, Seron K, Rouille Y, Dubuisson J. 2017. Entry and release of hepatitis C virus in polarized human hepatocytes. J Virol 10.1125/JVI.00478-17. - DOI - PMC - PubMed
    1. Berger DR, Ware BR, Davidson MD, Allsup SR, Khetani SR. 2015. Enhancing the functional maturity of induced pluripotent stem cell-derived human hepatocytes by controlled presentation of cell–cell interactions in vitro. Hepatology 61: 1370–1381. - PubMed